Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.
暂无分享,去创建一个
Aijaz Ahmed | Z. Younossi | Aijaz Ahmed | R. Wong | S. Harrison | R. Cheung | M. Aguilar | Stephen A Harrison | Zobair M Younossi | R. Perumpail | Robert J Wong | Maria Aguilar | Ramsey Cheung | Ryan B Perumpail
[1] M. Stepanova,et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[2] T. Therneau,et al. A model to predict survival in patients with end‐stage liver disease , 2001 .
[3] M. Taniguchi. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry. , 2012, Clinical transplants.
[4] R. Merion,et al. Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit , 2009, Hepatology.
[5] I. Popescu,et al. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time , 2005, Transplant international : official journal of the European Society for Organ Transplantation.
[6] G. Dore,et al. Epidemiology and natural history of HCV infection , 2013, Nature Reviews Gastroenterology &Hepatology.
[7] Katherine M Flegal,et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. , 2012, JAMA.
[8] Robert A Fisher,et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C , 2006, Hepatology.
[9] Z. Younossi,et al. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. , 2008, Journal of hepatology.
[10] J. Heimbach,et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. , 2011, Gastroenterology.
[11] James G Kench,et al. Long‐term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C , 2003, Hepatology.
[12] G. Davis,et al. Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[13] A. Baranova,et al. Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.
[14] A. Barritt,et al. Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[15] K. Cusi,et al. Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.
[16] J. Ward,et al. Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 , 2014, Annals of Internal Medicine.
[17] T. Therneau,et al. Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. , 2009, Gastroenterology.
[18] G. Colditz,et al. The disease burden associated with overweight and obesity. , 1999, JAMA.
[19] K. Batts,et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[20] Yeong-Seok Im,et al. Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List , 2009 .
[21] Z. Younossi,et al. 6 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH HIGHER OVERALL MORTALITY AND LIVER RELATED MORTALITY , 2008 .
[22] S. Saab,et al. Major Challenges Limiting Liver Transplantation in the United States , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[23] Aijaz Ahmed,et al. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. , 2014, Hepatology.
[24] F. Schaffner,et al. Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.
[25] T. Harris,et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. , 2006, The New England journal of medicine.
[26] D. Lawlor,et al. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. , 2007, Gastroenterology.
[27] S. Harrison,et al. NASH and HCC. , 2009, Clinics in liver disease.
[28] S. Sanderson,et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.
[29] S. Shiboski,et al. Projected future increase in aging hepatitis C virus–infected liver transplant candidates: A potential effect of hepatocellular carcinoma , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.